Literature DB >> 22121050

Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections.

Katarzyna Niespodziana1, Kamila Napora, Clarissa Cabauatan, Margarete Focke-Tejkl, Walter Keller, Verena Niederberger, Maria Tsolia, Ioannis Christodoulou, Nikolaos G Papadopoulos, Rudolf Valenta.   

Abstract

Rhinoviruses (RVs) are the primary cause of upper respiratory tract infections, generally known as the common cold. Moreover, RV infections can trigger severe exacerbations of asthma and chronic obstructive pulmonary disease (COPD). We expressed the 4 major RV capsid proteins, VP1-VP4, in Escherichia coli and used these proteins as well as recombinant and synthetic VP1 fragments to study and map antibody responses in RV-infected humans. VP1, which on infection binds to ICAM 1, was identified as a major target for the memory immune response, residing in the IgG1 subclass and IgA class. Interestingly, this response was mainly directed against an N-terminal 20 mer peptide in VP1, P1a, which becomes exposed on intact RV only when it docks to its receptor ICAM 1. Molecular modeling using the 3-dimensional RV capsid structures revealed that P1a was localized inside the capsid and outside the areas involved in receptor binding or RV neutralization. Our results suggest misdirection of antibody responses against a nonprotective epitope as a mechanism how RV escapes immunity and causes recurrent infections. Based on these findings, it may be possible to design vaccines against RV infections and RV-induced respiratory diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22121050     DOI: 10.1096/fj.11-193557

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C.

Authors:  Cibele M Gaido; Shane Stone; Abha Chopra; Wayne R Thomas; Peter N Le Souëf; Belinda J Hales
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  MUW researcher of the month.

Authors:  Katarzyna Niespodziana
Journal:  Wien Klin Wochenschr       Date:  2019-02       Impact factor: 1.704

3.  Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma.

Authors:  Spyridon Megremis; Katarzyna Niespodziana; Clarissa Cabauatan; Paraskevi Xepapadaki; Marek L Kowalski; Tuomas Jartti; Claus Bachert; Susetta Finotto; Peter West; Sofia Stamataki; Anna Lewandowska-Polak; Heikki Lukkarinen; Nan Zhang; Theodor Zimmermann; Frank Stolz; Angela Neubauer; Mübeccel Akdis; Evangelos Andreakos; Rudolf Valenta; Nikolaos G Papadopoulos
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

4.  A Single Point Mutation in the Rhinovirus 2B Protein Reduces the Requirement for Phosphatidylinositol 4-Kinase Class III Beta in Viral Replication.

Authors:  Pascal S Roulin; Luca P Murer; Urs F Greber
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

5.  Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms.

Authors:  Katarzyna Niespodziana; Clarissa R Cabauatan; David J Jackson; Daniela Gallerano; Belen Trujillo-Torralbo; Ajerico Del Rosario; Patrick Mallia; Rudolf Valenta; Sebastian L Johnston
Journal:  EBioMedicine       Date:  2014-11-18       Impact factor: 8.143

6.  Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.

Authors:  Jua Iwasaki; Wendy-Anne Smith; Shane R Stone; Wayne R Thomas; Belinda J Hales
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

7.  ELISA-Based Assay for Studying Major and Minor Group Rhinovirus-Receptor Interactions.

Authors:  Petra Pazderova; Eva E Waltl; Verena Niederberger-Leppin; Sabine Flicker; Rudolf Valenta; Katarzyna Niespodziana
Journal:  Vaccines (Basel)       Date:  2020-06-18

8.  Multiplexed High-Throughput Serological Assay for Human Enteroviruses.

Authors:  Niila V V Saarinen; Jussi Lehtonen; Riitta Veijola; Johanna Lempainen; Mikael Knip; Heikki Hyöty; Olli H Laitinen; Vesa P Hytönen
Journal:  Microorganisms       Date:  2020-06-26

Review 9.  COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.

Authors:  B Robson
Journal:  Comput Biol Med       Date:  2020-04-11       Impact factor: 4.589

10.  Microarray Technology May Reveal the Contribution of Allergen Exposure and Rhinovirus Infections as Possible Triggers for Acute Wheezing Attacks in Preschool Children.

Authors:  Katarzyna Niespodziana; Katarina Stenberg-Hammar; Nikolaos G Papadopoulos; Margarete Focke-Tejkl; Peter Errhalt; Jon R Konradsen; Cilla Söderhäll; Marianne van Hage; Gunilla Hedlin; Rudolf Valenta
Journal:  Viruses       Date:  2021-05-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.